Evaluating the utility of multi-gene, multi-disease population-based panel testing accounting for uncertainty in penetrance estimates
Abstract Panel germline testing allows for the efficient detection of deleterious variants for multiple conditions, but the benefits and harms of identifying these variants are not always well understood.We present a multi-gene, multi-disease aggregate utility formula that allows the user to consider adding or removing each gene in a panel based on